A reduction in 24-hour heart rate variations was linked to twice the risk for long-term cardiovascular death, while the inability to reduce heart rate during sleep was linked to 39% increased risk.

Patients may soon have a second drug class available to slow the progression of transthyretin-mediated amyloidosis with cardiomyopathy, a fatal disease, results of the HELIOS-B trial indicates.

Professor Ji-Guang Wang has spent his career treating and researching hypertension in China, where rates have risen from 10% to 30% in the past three decades.

"The current economy is brain unhealthy," said Harris Eyre, MD, PhD, of the Neuro-Policy Program and Harry Z. Yan and Weiman ...

An analysis of short-term dietary changes indicated that it resulted in less changes in gut-derived appetite hormones than ...

HOUSTON — A new analysis hints that there may be a benefit from aspirin for hospitalized patients with leukemia. In a preliminary study, researchers found that aspirin users had much lower odds of ...

Hispanic/Latinx and Black patients are underrepresented in immune checkpoint inhibitor clinical trials, but recent years have ...

More collaboration between cardiac and vascular specialists as well as the cardiovascular applications of artificial ...

These findings support the use of both neoadjuvant and adjuvant nivolumab in patients with resectable NSCLC, Patrick M. Forde ...

Dementia risk in older adults varied significantly by region across the country, particularly among Black or Hispanic ...

The new discounted single-dose formulation will likely improve access to low doses of the weight loss drug for certain ...

Balloon angioplasty plus medical management offered better outcomes in patients with symptomatic intracranial atherosclerotic ...